LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
LIM domain kinases as potential therapeutic targets for neurofibromatosis type 2
Authors
Keywords
-
Journal
ONCOGENE
Volume 33, Issue 27, Pages 3571-3582
Publisher
Springer Nature
Online
2013-08-12
DOI
10.1038/onc.2013.320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A functional cooperativity between Aurora A kinase and LIM kinase1
- (2012) Lisa Ritchey et al. CELL CYCLE
- Aurora A kinase (AURKA) in normal and pathological cell division
- (2012) Anna S. Nikonova et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Recent Findings Confirm LIM Domain Kinases as Emerging Target Candidates for Cancer Therapy
- (2012) F. Manetti CURRENT CANCER DRUG TARGETS
- Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus
- (2012) Wei Li et al. EMBO REPORTS
- LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy
- (2012) E. O. Johnson et al. JOURNAL OF CELL SCIENCE
- The Actin-Severing Protein Cofilin Is Downstream of Neuregulin Signaling and Is Essential For Schwann Cell Myelination
- (2012) N. Sparrow et al. JOURNAL OF NEUROSCIENCE
- Neurofibromatosis 2011: a report of the Children’s Tumor Foundation Annual Meeting
- (2011) Michel Kalamarides et al. ACTA NEUROPATHOLOGICA
- LIM kinases are attractive targets with many macromolecular partners and only a few small molecule regulators
- (2011) Fabrizio Manetti MEDICINAL RESEARCH REVIEWS
- Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression
- (2011) Brice V McConnell et al. Molecular Cancer
- Merlin, a “Magic” Linker Between the Extracellular Cues and Intracellular Signaling Pathways that Regulate Cell Motility, Proliferation, and Survival
- (2010) Ivan Stamenkovic et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Regulation of Vascular Endothelial Growth Factor-induced Endothelial Cell Migration by LIM Kinase 1-mediated Phosphorylation of Annexin 1
- (2010) Maxime C. Côté et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Schwannomin/merlin promotes Schwann cell elongation and influences myelin segment length
- (2010) Courtney Thaxton et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Neurofibromatosis type 2
- (2009) Ashok R Asthagiri et al. LANCET
- Hearing Improvement after Bevacizumab in Patients with Neurofibromatosis Type 2
- (2009) Scott R. Plotkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- LIM-kinase 2, a regulator of actin dynamics, is involved in mitotic spindle integrity and sensitivity to microtubule-destabilizing drugs
- (2009) S T Po'uha et al. ONCOGENE
- Validation of the p21-Activated Kinases as Targets for Inhibition in Neurofibromatosis Type 2
- (2008) C. Yi et al. CANCER RESEARCH
- Suppression of the Invasive Capacity of Rat Ascites Hepatoma Cells by Knockdown of Slingshot or LIM Kinase
- (2008) Yuji Horita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of a nonkinase target mediating cytotoxicity of novel kinase inhibitors
- (2008) P. Ross-Macdonald et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More